SEPAR guidelines for lung cancer staging;Normativa SEPAR sobre estadificación del cáncer de pulmón

Archivos de Bronconeumologia

Volumn 47, Issue 9, 2011, Pages 454-465

  Sánchez de Cos, Julio ^a   Hernández Hernández, Jesús ^b   Jiménez López, Marcelo F ^c   Padrones Sánchez, Susana ^d   Rosell Gratacós, Antoni ^d   Rami Porta, Ramón ^e  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^b HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Lung cancer; Staging; TNM IASLC classification

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOBRONCHIAL ULTRASONOGRAPHY; ESOPHAGEAL ULTRASOUND; HISTOPATHOLOGY; LUNG CANCER; LYMPH NODE; MEDIASTINUM METASTASIS; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; TUMOR VOLUME;

EID: 80052491819     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2011.06.007     Document Type: Article

References (69)

1. Rami Porta R., Duque Medina J.L., Hernández Hernández J.R., López Encuentra A., Sánchez de Cos J. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol 1998, 34:437-452. Grupo de trabajo de SEPAR.
2. Staging Manual in Thoracic Oncology 2009, Rx Press, Orange Park, Florida, USA. P. Goldstraw (Ed.).
3. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
4. Rusch V.W., Crowley J., Giroux D.J., Goldstraw P., Im J.G., Tsuboi M., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:603-612.
5. Postmus P.E., Brambilla E., Chansky K., Crowley J., Goldstraw P., Patz E.F., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007, 2:686-693.
6. Shepherd F.A., Crowley J., Van Houtte P., Postmus P.E., Carney D., Chansky K., et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007, 2:1067-1077.
7. Travis W.D., Giroux D.J., Chansky K., Crowley J., Asamura H., Brambilla E., et al. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2008, 3:1213-1223.
8. Rusch V.W., Asamura H., Watanabe H., Giroux D.J., Rami-Porta R., Goldstraw P The IASLC lung cancer staging project. A proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:568-577. on behalf of the members of the IASLC staging committee.
9. Quint L.E., Francis I.R., Gross B.H. Conventional imaging of non-small cell lung cancer. Lung Cancer. Principles and Practice 2005, 315-344. Lippincott Williams & Wilkins, Philadelphia (USA). H.L. Pass, D.P. Carbone, D.H. Johnson, J.D. Minna, A.T. Turrisi (Eds.).
10. Silvestri G.A., Gould M.K., Margolis M.L., Tanoue L.T., McCrory D., Toloza E., et al. Non invasive mediastinal Staging of Lung Cancer. ACCP Evidenced-Based Clinical Practice. Guidelines (2nd edition). Chest 2007, 132:178S-201S.
11. Tournoy K.G., Maddens S., Gosselin R., Van Maele G., Van Meerbeeck J.P., Kelles A. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Thorax 2007, 62:696-701.
12. De Wever W., Vankan Y., Stroobants S., Verschakelen J. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 2007, 29:995-1002.
13. Hwangbo B., Kim S.K., Lee H.S., Lee H.S., Kim M.S., Lee J.M., et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2009, 135:1280-1287.
14. De Langen A.J., Raijmakers P., Riphagen I., Paul M.A., Hoekstra O.S. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 2006, 29:26-29.
15. De Leyn P., Lardinois D., Van Schil P.E., Rami-Porta R., Passlick B., Zielinski M., et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007, 32:1-8.
16. Fischer B., Lassen U., Mortensen J., Larsen S., Loft A., Bertelsen A., et al. Preoperative astaging of lung cancer with combined PET-CT. N Eng J Med 2009, 361:32-39.
17. Mac Manus M., Nestle U., Rosenxweig K.E., Carrió I., Messa C., Belohlavek O., et al. Use of PET and PET/CT for Radiation Therapy Plannning IAEA expert report 2006-2007. Radioth Oncol 2009, 91:85-94.
18. De Wever W., Stroobants S., Coolen J., Verschakelen J.A. Integrated PET/CT in the staging of nonsmall cell lung cancer: Technical aspects and clinical integration. Eur Respir J 2009, 33:201-212.
19. Pfister D.G., Johnson D.H., Azzoli ChG, Sause W., Smith T.J., Baker S.H., et al. American Society of Clinical Oncology. Treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004, 22:330-353.
20. Rosell A., Ginés A., Serra M., Gámez C. Estadificación mediastínica del cáncer de pulmón en el siglo xxi: un reto de carácter multidisciplinario. Med Clin (Barc) 2008, 130:415-422.
21. Detterbeck F.C., Jantz M.A., Wallace M., Vansteenkiste J., Silvestri G.A. Invasive mediastinal Staging of Lung Cancer. ACCP evidence-Based Clinical Practice Guidelines (2nd edition). Chest 2007, 132:202S-220S.
22. Herth F., Becker H.D., Ernst A. Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest 2004, 125:322-325.
23. Harewood G.C., Pascual J., Raimondo M., Woodward T., Johnson M., McComb B., et al. Economic analysis of combined endoscopic and endobronchial ultrasound in the evaluation of patients with suspected non-small cell lung cancer. Lung Cancer 2009, 10.1016/j.lungcan2009.04.019.
24. Gu P., Zhao Y.Z., Jiang L.Y., Zhang W., Xin Y., Han B.H. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis. Eur J Cancer 2009, 45:1389-1396.
25. Lee H.S., Lee G.K., Lee H.S., Kim M.S., Lee J.M., Kim H.Y., et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?. Chest 2008, 134:368-374.
26. Herth F.J., Ernst A., Eberhardt R., Vilmann P., Dienemann H., Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J 2006, 28:910-914.
27. Herth F.J., Eberhardt R., Krasnik H., Ernst M.A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest 2008, 133:887-891.
28. Wallace M.B., Pascual J.M., Raimondo M., Woodward T.A., McComb B.L., Crook J.E., et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008, 299:540-546.
29. Micames C.G., McCrory D.C., Pavey D.A., Jowell P.S., Gress F.G. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging. A sistematic review and metaanalysis. Chest 2007, 131:539-548.
30. Fernández-Esparrach G., Ginés A., Belda J., Pellisé M., Solé M., Marrades M., et al. Transesophageal ultrasounf-guided fine needle aspiration improves mediastinal staging in patients with non-small cell lung cancer and normal mediastinum on computed tomography. Lung cancer 2006, 54:35-40.
31. Singh P., Camazine B., Jadhav Y., Gupta R., Mukhopadhyay Ph, Khan A., et al. Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer. Am J Respir Crit Care Med 2007, 175:345-354.
32. Varadarajulu S., Schmulewitz N., Wildi S.M., Roberts S., Ravenel J., Reed C.E., et al. Accuracy of EUS in staging of T4 lung cancer. Gastrointest Endosc 2004, 59:345-348.
33. Larsen S.S., Vilmann P., Krasnik M., Dirksen A., Clementsen P., Maltbaek N., et al. Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: preliminary results from a randomised trial. Lung Cancer 2005, 49:377-385.
34. Vassallo B., Martín de Nocolás Serrahima Métodos quirúrgicos de estadificación clínica. Estadificación del carcinoma broncogénico 2005, 163-187. Caduceo Multimedia, SL, Barcelona. B. Vasallo, J.L. Bravo Bravo, J.L. Duque Medina, A. López Encuentra, R. Rami Porta (Eds.).
35. Serra M., Rami R., Belda J., Call S., González G., Bastús R., et al. Análisis de los falsos negativos de la exploración quirúrgica sistemática del mediastino en pacientes afectos de un carcinoma broncogénico candidatos a tratamiento quirúrgico. Arch Bronconeumol 2005, 41(Especial Congreso):90-91.
36. Ginsberg R.J., Rice T.W., Goldberg M., Waters P.F., Schmocker B.J. Extended cervical mediastinoscopy. A single staging procedure for bronchogenic carcinoma of the left upper lobe. J Thorac Cardiovasc Surg 1987, 94:673.
37. López L., Varela A., Freixinet J., Quevedo S., López Pujol J., Rodríguez de Castro F., et al. Extended cervical mediastinoscopy: prospective study of fifty cases. Ann Thorac Surg 1994, 57:555-558.
38. Freixinet Gilart J., Gámez García P., Rodríguez de Castro P., Rodríguez Suárez P., Santana Rodríguez N., Varela de Ugarte A. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma. Ann Thorac Surg 2000, 70:1641-1643.
39. Call S., Rami-Porta R., Serra-Mitjans M., Saumench R., Bidegain C., Iglesias M., et al. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung. Eur J Cardiothorac Surg 2008, 34:1081-1084.
40. Jimémez Merchán R., Congregado Loscertales M., Gallardo Valera G., Triviño Ramírez A., Ayarra Jarne J., Loscertales J. Videotoracoscopia exploradora y videopericardioscopia en la estadificación definitiva y valoración de la resecabilidad del cáncer de pulmón. Arch Bronconeumol 2009, 45:435-441.
41. Hürtgen M., Friedel G., Toomes H., Fritz P. Radical video-assisted mediastinoscopic lymphadenectomy (VAMLA) - technique and first results. Eur J Cardiothorac Surg 2002, 21:348-351.
42. Leschber G., Holinka G., Linder A. Video-assisted mediastinoscopic lymphadenectomy (VAMLA) - a method for systematic mediastinal lymph node dissection. Eur J Cardiothorac Surg 2003, 24:192-195.
43. Zielinski M. Transcervical extended mediastinal lymphadenectomy: results of staging in two hundred fifty-six patients with non-small cell lung cancer. J Thorac Oncol 2007, 2:370-372.
44. Lardinois D., Schallberger A., Betticher D., Ris H.B. Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patietns without pretreatment for potentially operable non-small cell lung cancer. Ann Thorac Surg 2003, 75:1102-1106.
45. Van Schil P., van der Schoot J., Poniewierski J., Pauwels M., Carp L., Germonpré P., et al. Remediastinoscopy alter neoadjuvant therapy for non-small cell lung cancer. Lung Cancer 2002, 37:281-285.
46. De Leyn P., Stroobants S., De Wever W., Lerut T., Coosemans W., Decker G., et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease alter induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer: A Leuven Lung Cancer Group Study. J Clin Oncol 2006, 24:3333-3339.
47. De Waele M., Serra-Mitjans M., Hendriks J., Lauwers P., Belda-Sanchis J., Van Schil P., et al. Accuracy and survival of repeat mediastinoscopy alter induction therapy for non-small cell lung cancer in a combined series of 104 patients. Eur J Cardiothroac Surg 2008, 33:824-828.
48. Marra A., Hillejan L., Fechner S., Stamatis G. Remediastinoscopy in restaging of lung cancer after induction therapy. J Thorac Cardiovasc Surg 2008, 135:843-849.
49. Zielinski M., Hauer L., Hauer J., Pankowski J., Nabialek T., Szlubowski A. Non-small cell lung cancer restaging with the transcervical extended mediastinal lymphadenectomy. Interac Cardiovasc Thorac Surg 2009, 9(Suppl 1):S16.
50. Jaklitsch M.T., Gu L., Harpole D.H., D'Amico T.A., McKenna R.J., Krasna M.J., et al. CALGB thoracic surgeons. Prospective phase II trial of pre-resection thoracoscopy (VATS) restaging following neoadjuvant therapy for IIIA (N2) non-small cell lung cancer (NSCLC): results of CALGB 39803. J Clin Oncol 2005, 23(Suppl 1):7065.
51. Herth F.J., Annema J.T., Eberhardt R., Yasufuku K., Ernst A., Krasnik M., et al. Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol 2008, 26:3346-3350.
52. Stigt J.A., Oostdijk A.H., Timmer P.R., Shahin G.M., Boers J.E., Groen H.J. Comparison of EUS-guided fine needle aspiration and integrated PET-CT in restaging after treatment for locally advanced non-small cell lung cancer. Lung Cancer 2009, 66:198-204.
53. Rice T.W., Blackstone E.H. Radical resections for T4 lung cancer. Surg Clin North Am 2002, 82:573-587.
54. Jett J.R., Schild S.E., Keith R.L., Kesler K.A. Treatment of non-small cell lung cancer, stage IIIB. Chest 2007, 132:266S-276S.
55. GCCB-S (Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica) Estadificación ganglionar intraoperatoria en la cirugía del carcinoma broncogénico. Documento de consenso. Arch Bronconeumol 2001, 37:495-503.
56. Wright G., Manser R.L., Byrnes G., Hart D., Campbell D.A. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax 2006, 61:597-603.
57. Lardinois D., De Leyn P., Van Schil P.E., Rami Porta R., Waller D., Passlick B., et al. ESTS guidelines for intraoperative lymph node staging in nonsmall cell lung cancer. Eur J Cardiothorac Surg 2006, 30:787-792.
58. Naruke T., Tsuchiya R., Kondo H., Nakayama H., Asamura H. Lymph node sampling in lung cancer: how should it be done?. Eur J Cardiothorac Surg 1999, 16:S17-S24.
59. Ichinose Y., Kato H., Koike T., Tsuchiya R., Fujisawa T., Shimizu N., et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumour location and N2 station. J Thorac Cardiovasc Surg 2001, 122:803-808. Japanese Clinical Oncology Group.
60. Scott W.J., Howington J., Feigenberg S., Movsas B., Pisters K. Treatment of non-small cell lung cancer stage I and stage II. Chest 2007, 132:234S-242S.
61. McKenna R.J., Houck W., Fuller C.B. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006, 81:421-426.
62. Jiménez M.F., Varela G., Novoa N., Aranda J.L. La lobectomía broncoplástica frente a la neumonectomía en el tratamiento del carcinoma de pulmón no microcítico. Arch Bronconeumol 2006, 42:160-164.
63. Rami-Porta R., Wittekind C., Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005, 49:25-33. International Association for the Study of Lung Cancer (IASLC) Staging Committee.
64. Schwartz A.M., Henson D.E. Diagnostic surgical pathology in lung cancer. Chest 2007, 132:78S-93S.
65. Travis W.D., Brambilla E., Rami-Porta R., Vallières E., Tsuboi M., Rusch V., et al. Visceral pleural invasion: pathologic criteria and use of elastic stains. Proposals for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008, 3:1389-1390. on behalf of the International Staging Committee.
66. Brock M.V., Hooker C.M., Machida E., Han Y., Guo M., Ames S., et al. DNA methylation markers and early recurrence in stage I lung cancer. N Eng J Med 2008, 358:1118-1128.
67. Benlloch S., Galbis-Carvajal J.M., Alenda C., Peiro F.M., Sánchez J., Rodríguez J.M., et al. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potencial role as markers of occult micrometastases. Annal Oncol 2009, 20:91-97.
68. Pellisé M., Castells A., Ginés A., Agrelo R., Solé M., Castellví-Bel S., et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography-guided fine-needle aspiration biopsy. Clin Cancer Res 2004, 10:4444-4449.
69. Wallace M.B., Block M.I., Gillanders W., Ravenel J., Hoffman B.J., Reed C.E., et al. Accurate molecular detection of NSCLC metastases in mediastinal lymph nodes sampled by endoscopic guided needle aspiration. Chest 2005, 127:430-437.